Sensus Healthcare (SRTS)
(Delayed Data from NSDQ)
$6.44 USD
+0.06 (0.94%)
Updated Aug 28, 2024 04:00 PM ET
After-Market: $6.44 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
C Value C Growth A Momentum B VGM
Brokerage Reports
Sensus Healthcare, Inc. [SRTS]
Reports for Purchase
Showing records 1 - 20 ( 104 total )
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
2Q24 Another Strong Q and Strong Initial Uptake of Fair Deal Arrangements
Provider: Roth Capital Partners, Inc.
Analyst: WITTES J
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
Revenue Grew Over 200% in 1Q24: Reiterate Buy; Raising PT to $10
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
Full-Year 2023 Financial Results Reported: Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
4Q23 Financial Performance Surpasses Expectations: Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
We are updating our Healthcare coverage to reflect a recent analyst departure and to drop
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
2Q23 Recap - Starting to Build Positive Momentum
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
Revenue Miss, Bottom-Line Beat; 2Q23 Financial Results; Lowering PT to $8
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
Turnaround Opportunity? Tune-In June 13 (10AM ET)
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
1Q23 Results Impacted by Lower Demand: Reiterate Buy; Lowering PT to $10
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y